The results show a higher rate of MPR achievement following treatment with NCIO in patients with the following characteristics: an earlier N classification (Figure 2A, P = 0.021), a radiographic response of PR (Figure 2B, P < 0.001), a smaller tumor burden (Figure 2D, P = 0.001), and a higher pre-treatment tumor tissue PD-L1 expression level (Figure 2E, P = 0.003), additionally, those without obstructive pneumonia/atelectasis (Figure 2C, P = 0.039). The gene discussed is CD274; the disease is neoplasm.